Biochips are small devices capable of detecting and measuring large number of biomarkers simultaneously. The development of biochips is a major thrust of the rapidly growing biotechnology industry in the US. The demand for biochips and its related products is foreseen to rise by approximately ten percent by 2018.
Profits will definitely be a consequence of major contributions by microarray automation and cost efficiency of products. Though the industry’s future growth will be repressed by aggravated competition and advances in alternate DNA technologies, with advancing genomic and proteomic technologies, this sector is set to grow and flourish.
The biochip service demand is foreseen to encounter a greater rise as compared to the biochip segment.
The biochip industry is in the early stages of growth and hence, not only promises potential but is also susceptible to vagaries of market forces. Competition, patent disputes, knowledge constraints (in terms of skilled employees, technical know-how) and financial strength might be a few impediments for firms engaged in this industry. In the United States, the leading suppliers of biochip products and services in 2014 were Illumina, Life Technologies and Affymetrix.
The biochip industry is characterized by both intense rivalry and an equally well-developed web of alliances. There are numerous smaller companies and hence it is no surprise that the bigger companies are able to buy their way into the market. Therefore, what will be interesting to see is how these corporations play themselves out in the coming times, with the industry set for an all time high in its growth.
In this industry scenario, TaiyouReports.com analyzes the US Biochips Market. The report covers the following:
• An overview of what are biochips, the history of biochips, fabrication process of microarrays, and the development of protein biochip arrays.
• An analysis of the US biochips industry focusing on a market profile, demand for biochips in the US, the demand for biochip products that is segmented into biochips (microarrays), reagents and consumables, and other biochip products.
• An analysis of the demand for biochip services in the US.
• Industry trends and trade scenario for biochips in the US.
• Applications of biochips in the US are analyzed through a segmentation of applications in drug discovery, in vitro diagnostic testing, life science research, and other applications.
• Technological innovation in the industry including biochip technology in use in the US market along with an analysis of competing technologies.
• Competition in the industry is analyzed and it sets the profile for an analysis of the major industry players such as Affymetrix, Illumina Inc, and Life Technologies Corporation. Other players such as Agilent Technologies, Beckman Coulter Inc, and others are also analyzed in the report.
• Industry forecast is included for the overall biochips market in the US, demand forecast for biochip products including forecast for biochips (Microarrays), reagents and consumables, and other biochip products. Demand forecast for biochip services is also included, along with an industry forecast according to applications.
Check out our latest report today @ : http://bit.ly/1Eae4tk
Contact Details:
TaiyouReports.com
Eliana Bose
press@taiyoureports.com
info@taiyoureports.com